Can a simple blood test predict the best eye treatment for diabetes patients?
NCT ID NCT06984822
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is for people with diabetic macular edema, a condition that causes vision loss. Researchers want to see if certain substances in the blood and patterns on eye scans can predict how well a patient will respond to two common treatments: anti-VEGF injections or a dexamethasone implant. The goal is to find markers that help doctors choose the right treatment for each person. The study will enroll 150 adults and does not test a new drug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Anti-VEGF treatment or Dexamethasone implant
What this could lead to
If successful, this could help doctors choose the best treatment for each patient with diabetic macular edema, improving vision outcomes.
What could go wrong
This is an observational study, not a treatment trial. It will not directly test if one drug is better, and results may not change practice immediately.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sahlgrenska University Hospital, Department of Ophthalmology
RECRUITINGMölndal, 431 80, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ögonmottagning Mölndal/SU
NOT_YET_RECRUITINGMölndal, 43130, Sweden
Contact Phone: •••-•••-••••
Contact Phone: •••-•••-•••• Email: •••••@•••••